Tilray, Inc. (TLRY) Reports In-Line Q2 EPS, Revenue Misses Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Turkish Stocks Fall 6%, Triggering Market-wide Circuit Breaker - Bloomberg
Tilray, Inc. Reports First Quarter Fiscal Year 2022 Financial Results
October 7, 2021 7:00 AM EDTNet Revenue and Gross Profit Increased 43% and 46%, Respectively, for Largest Global Cannabis Cultivator
10th Consecutive Quarter of Positive Adjusted EBITDA
$55 Million in Cost-Savings Achieved On a Run-Rate Basis To Date; On-track for at Least $80 Million in Cost-Savings from Aphria and Tilray Synergies
#1 Leading Market Share in Canada1 with Comprehensive Portfolio of Medical and Adult-Use Cannabis Brands, International Market Leader and #1 in Germany2 with Medical Cannabis Extracts
NEW YORK & LEAMINGTON, Ontario--(BUSINESS WIRE)-- Tilray, Inc. (Tilray or the Company) (Nasdaq:... More
